Home/Filings/4/0000899243-20-033926
4//SEC Filing

mccormack riley 4

Accession 0000899243-20-033926

CIK 0001438231other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 7:03 PM ET

Size

12.2 KB

Accession

0000899243-20-033926

Insider Transaction Report

Form 4
Period: 2020-12-11
mccormack riley
DirectorChief Executive Officer10% Owner
Transactions
  • Conversion

    Common Stock

    2020-12-11$14.37/sh+1,198,161$17,217,5743,740,240 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2020-12-1116,9700 total(indirect: See Footnote)
    Exercise: $14.37Common Stock (1,198,161 underlying)
Holdings
  • Common Stock

    6,546
Transactions
  • Conversion

    Common Stock

    2020-12-11$14.37/sh+1,198,161$17,217,5743,740,240 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2020-12-1116,9700 total(indirect: See Footnote)
    Exercise: $14.37Common Stock (1,198,161 underlying)
Holdings
  • Common Stock

    6,546
Transactions
  • Conversion

    Common Stock

    2020-12-11$14.37/sh+1,198,161$17,217,5743,740,240 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2020-12-1116,9700 total(indirect: See Footnote)
    Exercise: $14.37Common Stock (1,198,161 underlying)
Holdings
  • Common Stock

    6,546
Footnotes (2)
  • [F1]These shares of Series B Convertible Preferred Stock plus accrued but unpaid dividends (the "Series B Shares") became convertible into shares of Common Stock when the holders of Common Stock (other than the Reporting Persons) approved the issuance of shares of Common Stock upon conversion of the Series B Shares, as required under the listing rules of the Nasdaq Stock Market (the "Shareholder Approval"). Following receipt of the Shareholder Approval and subject to satisfaction of stock exchange listing requirements, the Series B Shares were automatically converted into shares of Common Stock at a conversion price equal to $14.37 per share. The Series B Shares have no expiration date.
  • [F2]The securities are directly owned by TCM Strategic Partners L.P. ("TCM Partners"). TCM Strategic GP LLC ("TCM GP") is the general partner of TCM Partners. Riley McCormack is the sole manager of TCM GP. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of its or his indirect pecuniary interest therein, and this report shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Issuer

Digimarc CORP

CIK 0001438231

Entity typeother

Related Parties

1
  • filerCIK 0001536534

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 7:03 PM ET
Size
12.2 KB